MAR 22, 2020 7:48 AM PDT

What is "Shotgun ion mobility mass spectrometry sequencing"?

Research published recently in Nature Communications highlights a new method of mapping an essential family of polysaccharides called GAGs (glycosaminoglycans). GAGs are critical to regulating many biological functions such as inflammation, neurodegeneration and tumor metastasis. One common type of GAG is called heparin and is currently used in clinical settings in an anticoagulant drug. Yet, aside from heparin, to date GAGs have been difficult to understand and only several structures have been accurately mapped.

Now the study from the Danish National Research Foundation Centre for Glycomics at the Department of Cellular and Molecular Medicine, University of Copenhagen, offers new insight on GAG mapping methods.

Photo: Pixabay

"Determining the structures is a key question in the research about sugars. If we know the structure, we can determine what the cues are for specific biological functions and consider potential ways to exploit this in the development of therapeutics. This is hugely important and clinically relevant, as shown by the widely used anti-coagulant heparins, and the potential application of new heparin-based drugs for multiple diseases in the future," says the corresponding author, Dr. Rebecca Louise Miller, who is an Assistant Professor at the Copenhagen Center for Glycomics.

The method that Dr. Miller and her team have developed is called "Shotgun ion mobility mass spectrometry sequencing" or SIMMS2. It’s a complicated name and an even more complicated process akin to breaking sugar structures into small puzzle pieces in order to identify their genetic fingerprints and compare them to know existing structures. Through this process, they are able to sequence larger GAG structures.

"The instrumentation behind this new method was invented by the company Waters Ltd in 2006 and is available to many pharmaceutical companies and researchers. This means that the method could be easily implemented and widely used for drug discovery by many research groups in a short period of time," says co-author Professor Jeremy Turnbull, University of Liverpool and Copenhagen Center for Glycomics.

The researchers plan to continue their investigations with GAGs, SIMMS2, and GAGOme (another method they developed) in hopes of improving the therapeutic effects of heparins in cancer and neurogenerative diseases like Parkinson’s.

Sources: Nature Communications, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
DEC 02, 2020
Immunology
A Shingles Vaccine for Cancer Patients
DEC 02, 2020
A Shingles Vaccine for Cancer Patients
Receiving a vaccine (usually in the form of an inactivated pathogen) triggers an immune response without the symptoms of ...
DEC 02, 2020
Cancer
Investigating the Active Components of an Herbal Mushroom
DEC 02, 2020
Investigating the Active Components of an Herbal Mushroom
When people think of traditional medicine, often what comes to mind are the old herbal medical practices in Asian countr ...
DEC 11, 2020
Cancer
Fan therapy proves to improve breathlessness in patients with advanced cancer
DEC 11, 2020
Fan therapy proves to improve breathlessness in patients with advanced cancer
New research released from Johns Hopkins Kimmel Cancer Center suggests that the air from fans may help patient ...
DEC 26, 2020
Clinical & Molecular DX
Navigating the Genomic Landscape of Cancer in Asians
DEC 26, 2020
Navigating the Genomic Landscape of Cancer in Asians
Precision medicine — a clinical paradigm that tailors treatments specifically to patients based on their genetic a ...
JAN 02, 2021
Cancer
Mothers and fathers take the financial toll of having a child with cancer differently
JAN 02, 2021
Mothers and fathers take the financial toll of having a child with cancer differently
A new study by researchers at Uppsala University in Sweden contemplates the socioeconomic impact on parents of having a ...
JAN 29, 2021
Genetics & Genomics
As Humans Evolved, Cancer Came Along
JAN 29, 2021
As Humans Evolved, Cancer Came Along
Humans are far more likely to get several types of cancerous tumors than our closest evolutionary cousins, chimpanzees. ...
Loading Comments...